SEC Form 4 · accession 0001415889-16-004790
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert N Fried
Director
Period of report
Jan 29, 2015
Accepted (ET)
Feb 16, 2016 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2016 | S | 5,063 | $1.26 | D | 155,937 | D | |
| Common StockF1 | holding | — | — | — | 38,232 | I | See Footnote 1 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F120,232 shares held by Jeremy Fried and 18,000 shares held by Benjamin Fried, who are both sons of Robert Fried.